Philippine Government Exceeds 2024 Fiscal Revenue Target with Surplus

Jan.21
Philippine Government Exceeds 2024 Fiscal Revenue Target with Surplus
Philippine government exceeds fiscal revenue target in 2024, thanks to increased tax and non-tax revenue, DOF data shows.

According to a report from the Philippine News Agency on January 20, data from the Department of Finance (DOF) of the Philippines shows that the government's fiscal revenue exceeded its target in 2024, primarily due to an increase in tax and non-tax revenues.


Preliminary data released by the Department of Finance (DOF) in the Philippines showed that as of January 16, total revenue reached 4.4 trillion Philippine pesos (750 billion USD), with the Bureau of Internal Revenue (BIR) collecting 2.86 trillion pesos (490 billion USD) in taxes. BIR Commissioner Romeo Lumagui Jr. attributed the agency's surplus in the billions of pesos in 2024 to good governance and enforcement actions against false receipts, illegal tobacco, and e-cigarette transactions.


The Customs Bureau (BOC) collected taxes amounting to 916 billion pesos (15.6 billion US dollars), while total tax revenue from other departments amounted to 323.8 billion pesos (5.5 billion US dollars).


Finance Minister Ralph Recto commended the performance of the BIR and BOC.


I believe that our revenue as a percentage of GDP reached a new high of 16.5% last year, the highest in 27 years. I look forward to the BIR continuing to meet their goals by 2025, although the task for the BOC will be more challenging as we have increased their revenue target.


Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.